A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG)
Clinical trial NCT02774239 · COMPLETED
Trial details
- NCT number
- NCT02774239
- Sponsor
- University of Alberta
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2022-10-21
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.